Taro Pharmaceutical (TARO) Q3 Earnings and Revenues Miss Estimates

Taro (TARO) delivered earnings and revenue surprises of -23.08% and 2.26%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?